文章摘要
WHO对年度优先关注突发传染病的评估方法介绍
Introduction of WHO annual assessment methodology for prioritized infectious diseases outbreaks
  
DOI:10.3969/j.issn.1007-8134.2019.05.001
中文关键词: 优先重点关注传染病研究与发展计划  优先重点关注传染病清单  突发性传染病  传染病应急  世界卫生组织
英文关键词: priority diseases under the R&D Blueprint  list of priority diseases under the R&D Blueprint  outbreaks of infectious diseases  emergency response to infectious diseases  WHO
基金项目:国家科技重大专项(2018ZX10102001)
作者单位
许庭莹 中国食品药品检定研究院体外诊断试剂所传染病诊断二室 
石大伟 中国食品药品检定研究院体外诊断试剂所传染病诊断二室 
刘东来 中国食品药品检定研究院体外诊断试剂所传染病诊断二室 
张春涛 中国食品药品检定研究院体外诊断试剂所传染病诊断二室 
摘要点击次数: 569
全文下载次数: 360
中文摘要:
      为完善全球范围内突发传染病的应急处理,WHO作为联合国权威卫生机构,从2015年12月开始,召集相关部门和行业专家,对可能引起全球流行性暴发且尚无合理应急预案或应急防治方案不健全的传染性疾病,进行公共卫生流行性风险评估。运用科学的统计评估方法,结合对突发传染病应急处理的经验,制定了优先重点关注传染性疾病研究与发展计划。该计划确定传染病的优先关注顺序标准及该标准的评估方法,发布年度优先重点关注传染病清单。旨在指导各国公共卫生部门、相关科研院所及企业单位加深交流合作,集中优势资源,迅速判断突发疫情发展趋势,高效获得相关病原体诊断试剂、救治药物和防控疫苗产品,快速隔离传染源并实施救治。
英文摘要:
      As the world authoritative health institutions, WHO has assembled relevant functions and industry experts to conduct a comprehensive assessment to the public health potential transmission risk of the infectious diseases since December 2015, mainly focusing on severe emerging diseases with potential to generate a public health outbreak worldwide, and for which insufficient or no preventive and curative solutions exist. WHO Research and Development Blueprint on prioritized infectious diseases has been formulated using the scientific methodology for statistics and assessment, and based on experience of emergency response to the outbreak of infectious diseases. This program determines the standard and assessment method for the priority infectious diseases, issues the annual list of infectious diseases prioritized under the Research and Development Blueprint. The program aims to guide public health departments, relevant scientific research institutes and enterprises to deepen the exchange and cooperation, concentrate superior resources, quickly identify a nascent outbreak, obtain the most advanced products including pathogen’s diagnostic reagents, remedial drugs and control vaccine products, isolate infection source and arrange medical treatment.
HTML   查看全文   下载PDF阅读器
关闭